Samarth Kulkarni Insider Trading for April 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Samarth Kulkarni.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Samarth Kulkarni for April 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Option Exercise | M | 1.81 | 2,206 | 3,993 | 294,558 | |
| Apr 28 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Option Exercise | M | 1.81 | 3,275 | 5,928 | 296,764 | |
| Apr 28 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Sell | S | 16.78 | 2,206 | 37,023 | 134,047 | 136.3 K to 134 K (-1.62 %) |
| Apr 28 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Buy | M | 1.81 | 2,206 | 3,993 | 136,253 | 134 K to 136.3 K (+1.65 %) |
| Apr 28 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Sell | S | 16.74 | 3,275 | 54,816 | 134,047 | 137.3 K to 134 K (-2.38 %) |
| Apr 28 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Buy | M | 1.81 | 3,275 | 5,928 | 137,322 | 134 K to 137.3 K (+2.44 %) |
| Apr 25 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Option Exercise | M | 1.81 | 5,115 | 9,258 | 300,039 | |
| Apr 25 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Option Exercise | M | 1.81 | 3,500 | 6,335 | 305,154 | |
| Apr 25 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Option Exercise | M | 1.81 | 3,000 | 5,430 | 308,654 | |
| Apr 25 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Sell | S | 16.87 | 5,115 | 86,290 | 134,047 | 139.2 K to 134 K (-3.68 %) |
| Apr 25 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Buy | M | 1.81 | 5,115 | 9,258 | 139,162 | 134 K to 139.2 K (+3.82 %) |
| Apr 25 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Sell | S | 16.46 | 3,500 | 57,619 | 134,047 | 137.5 K to 134 K (-2.54 %) |
| Apr 25 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Buy | M | 1.81 | 3,500 | 6,335 | 137,547 | 134 K to 137.5 K (+2.61 %) |
| Apr 25 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Sell | S | 17.01 | 3,000 | 51,033 | 134,047 | 137 K to 134 K (-2.19 %) |
| Apr 25 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Buy | M | 1.81 | 3,000 | 5,430 | 137,047 | 134 K to 137 K (+2.24 %) |
| Apr 21 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Option Exercise | M | 1.81 | 2,800 | 5,068 | 311,654 | |
| Apr 21 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Option Exercise | M | 1.81 | 7,258 | 13,137 | 314,454 | |
| Apr 21 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Sell | S | 17.36 | 2,800 | 48,621 | 134,047 | 136.8 K to 134 K (-2.05 %) |
| Apr 21 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Buy | M | 1.81 | 2,800 | 5,068 | 136,847 | 134 K to 136.8 K (+2.09 %) |
| Apr 21 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Sell | S | 18.54 | 2,449 | 45,393 | 134,047 | 136.5 K to 134 K (-1.79 %) |
| Apr 21 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Sell | S | 17.54 | 4,809 | 84,361 | 136,496 | 141.3 K to 136.5 K (-3.40 %) |
| Apr 21 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Business Offi ... | Buy | M | 1.81 | 7,258 | 13,137 | 141,305 | 134 K to 141.3 K (+5.41 %) |